EPO revokes Myriad patent

The European Patent Office revoked European Patent No. EP699754, which was granted to MYGN in 2001. The patent, known as the BRCA1-gene patent, covers "a method for diagnosing a predisposition for breast and ovarian cancer in a human subject, which comprises determining whether there is a germline alteration in the sequence of the BRCA1 gene or a BRCA1 gene regulatory sequence." ...